A phase 3 trial comparing doxorubicin-trabectedin combination therapy to doxorubicin alone in advanced leiomyosarcoma patients demonstrated a median overall survival of 33 months versus 24 months, respectively.

The TOPAZ-1 trial demonstrates that adding durvalumab to standard chemotherapy significantly improves overall survival in patients with advanced biliary tract cancer, potentially establishing a new first-line treatment option for this difficult-to-treat malignancy.

Medical errors are now recognized as the third leading cause of death in the US, emphasizing the urgent need for improved safety measures in healthcare settings.

Osimertinib significantly improved progression-free survival in patients with unresectable stage III EGFR-mutant NSCLC after chemoradiotherapy, with a hazard ratio of 0.16 compared to placebo.

One teaspoon of baking soda contains about 1,200 mg of sodium, nearly the full daily recommended allotment given by the American Heart Association for people with high blood pressure.

Intramuscular fat accumulation poses a significant mortality risk, potentially surpassing that of obesity and muscle wasting, according to recent research.